126 related articles for article (PubMed ID: 3009377)
1. Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes.
Yamada H; Sakamoto H; Taira M; Nishimura S; Shimosato Y; Terada M; Sugimura T
Jpn J Cancer Res; 1986 Apr; 77(4):370-5. PubMed ID: 3009377
[TBL] [Abstract][Full Text] [Related]
2. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation.
Yamada H; Yoshida T; Sakamoto H; Terada M; Sugimura T
Biochem Biophys Res Commun; 1986 Oct; 140(1):167-73. PubMed ID: 3778442
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
[TBL] [Abstract][Full Text] [Related]
5. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
Cui Q; Wang Z; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay.
Demeure MJ; Doffek KM; Komorowski RA; Wilson SD
Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
8. Activation of oncogenes in human oral cancer cells: a novel codon 13 mutation of c-H-ras-1 and concurrent amplifications of c-erbB-1 and c-myc.
Tadokoro K; Ueda M; Ohshima T; Fujita K; Rikimaru K; Takahashi N; Enomoto S; Tsuchida N
Oncogene; 1989 Apr; 4(4):499-505. PubMed ID: 2654810
[TBL] [Abstract][Full Text] [Related]
9. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
[TBL] [Abstract][Full Text] [Related]
10. Stability of ras oncogene mutation in the human tumor xenografts through serial passages.
Kijima H; Abe Y; Yamazaki H; Ohnishi Y; Ueyama Y; Tamaoki N; Nakamura M
Anticancer Res; 1994; 14(6B):2583-7. PubMed ID: 7872685
[TBL] [Abstract][Full Text] [Related]
11. Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor.
Hrasćan R; Pavelić K; Pavicić D; Krizanac S; Stajcer-Sittić V; Pecur L; Spaventi S; Klimpfinger M; Pavelić J
Anticancer Res; 1996; 16(6B):3761-6. PubMed ID: 9042254
[TBL] [Abstract][Full Text] [Related]
12. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
[TBL] [Abstract][Full Text] [Related]
13. [Biochemical and molecular biological aspects of stomach cancer development in human and animal].
Khanson KP; Kalinovskiĭ VP; Novikov LB; Fedorov SN
Vopr Med Khim; 1991; 37(6):84-8. PubMed ID: 1812623
[TBL] [Abstract][Full Text] [Related]
14. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.
Fukumoto M; Estensen RD; Sha L; Oakley GJ; Twiggs LB; Adcock LL; Carson LF; Roninson IB
Cancer Res; 1989 Apr; 49(7):1693-7. PubMed ID: 2647292
[TBL] [Abstract][Full Text] [Related]
15. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.
Abbruzzese JL; Evans DB; Raijman I; Larry L; King T; Leach SD; Frazier ML
Anticancer Res; 1997; 17(2A):795-801. PubMed ID: 9137410
[TBL] [Abstract][Full Text] [Related]
16. Activation of c-Ki-ras gene in human pancreatic cancer.
Prassolov VS; Sakamoto H; Nishimura S; Terada M; Sugimura T
Jpn J Cancer Res; 1985 Sep; 76(9):792-5. PubMed ID: 3932275
[TBL] [Abstract][Full Text] [Related]
17. c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance.
Schleger C; Verbeke C; Hildenbrand R; Zentgraf H; Bleyl U
Mod Pathol; 2002 Apr; 15(4):462-9. PubMed ID: 11950922
[TBL] [Abstract][Full Text] [Related]
18. [Expression of c-myc and c-ki-ras oncogene in human pancreatic carcinoma].
Li DC
Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):30-2. PubMed ID: 1396043
[TBL] [Abstract][Full Text] [Related]
19. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
[TBL] [Abstract][Full Text] [Related]
20. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
Radinsky R; Kraemer PM; Proffitt MR; Culp LA
Cancer Res; 1988 Sep; 48(17):4941-53. PubMed ID: 3409227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
